Relative safety and efficacy of topical and oral NSAIDs in the treatment of osteoarthritis: A systematic review and meta-analysis

• Published in: Medicine (Baltimore) 2022-09, Vol.101 (36), p.e30354-e30354
• Main Authors: Wang, Yuhui, Fan, Miaozhen, Wang, Huideng, You, Yi, Wei, Chengqiong, Liu, Meng, Luo, Ailin, Xu, Xiaotian, Duan, Xiaoqun
• Format: Article
• Language: English
• Subjects: Acetaminophen - therapeutic use; Anti-Inflammatory Agents, Non-Steroidal - adverse effects; Humans; Osteoarthritis - drug therapy; Pain - drug therapy; Quality of Life; Randomized Controlled Trials as Topic
• ISSN: 1536-5964; 1536-5964
• DOI: 10.1097/MD.0000000000030354

Osteoarthritis (OA) often affects the hands, knees, and hip joints, causing considerable pain and disability, and often affecting the patient's quality of life. Non-steroidal anti-inflammatory drugs (NSAIDs) are common pain relievers often applied as first line therapies for OA. However, prolonged NSAIDs application can have unwanted side effects. Given this, this study was designed to systematically evaluate the efficacy and safety of topical and oral NSAIDs for the treatment of OA. We searched the PubMed, Embase, Cochrane Library, and Web of Science databases for relevant papers from their inception dates to May 2021. Our study only included randomized controlled trials comparing topical and oral NSAIDs and all data were analyzed using Review Manager version 5.3 (RevMan version 5.3). We identified 8 RCTs (2096 patients with OA), for evaluation and revealed that, in general, topical and oral NSAIDs presented with similar efficacies for the treatment of OA. The Western Ontario and McMaster Osteoarthritis Index for assessing pain relief in OA patients was (standardized mean difference [SMD] 0.07; 95%CI -0.02, 0.17) and visual analog scale was (SMD -0.01; 95%CI -0.02, 0.18), and improved stiffness in OA patients (SMD 0.09; 95%Cl 0.03, 0.20). Topical NSAIDs are as effective as oral NSAIDs for the treatment of OA and both topical and oral NSAIDs are equally effective in reducing pain and improving physical function in OA patients. In terms of safety, a larger number of samples are still needed to determine if there are any differences in the safety profile of topical or oral NSAIDs. INPLASY 2021110009.